Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes

By M. Harel, A. Aharoni, L. Gaidukov, B. Brumshtein, O. Khersonsky, Ran Meged, H. Dvir, R. Ravelli, A. McCarthy, L. Toker and 3 more. Nature Structural &Molecular Biology, 2004

633 citations recorded by the source corpus.

Subfields: Biochemistry, Clinical Biochemistry, Plant Science

View Paper: https://www.semanticscholar.org/paper/bfc8e948096e522d1ce2042c82ea6bf34664d367

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biochemistry

1. J. Chapman
2. A. Kontush

Citations in the corpus

• Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis (2006, background): “terminus (Josse et al., 2002; Harel et al., 2004); the”
• Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains additional text, figures, and references. Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M (2005, background): “A directly evolved form of PON1 was crystallized very recently, and a model for PON1 association with HDL has been proposed ( 58 ).”